Malignant lymphoma of the tonsil in a patient with Behçet's disease

Joint Bone Spine

Volumn 75, Issue 5, 2008, Pages 616-618

  Souabni, Leila ^a   Elleuch, Mohamed ^a   Amira, Chiraz ^a   Sellami, Slaheddine ^a  

^a Hôpital la Rabtan   (Tunisia)

Author keywords

Beh et disease; Immunosuppressive agents; Lymphoma; Malignant

Indexed keywords

CD79A ANTIGEN; COLCHICINE; CYCLOPHOSPHAMIDE; DAPSONE; DOXORUBICIN; INDOMETACIN; LATENT MEMBRANE PROTEIN 1; PREDNISONE; VINCRISTINE;

ADULT; ARTICLE; B CELL LYMPHOMA; BEHCET DISEASE; BONE MARROW BIOPSY; BONE RADIOGRAPHY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CASE REPORT; CLINICAL EVALUATION; COMPUTER ASSISTED TOMOGRAPHY; DRUG DOSE INCREASE; DRUG TOLERABILITY; DRUG WITHDRAWAL; ERYTHROCYTE SEDIMENTATION RATE; FOLLOW UP; GASTROINTESTINAL ENDOSCOPY; GASTROINTESTINAL HEMORRHAGE; GENITAL ULCER; HEARING LOSS; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOHISTOLOGY; JOINT RADIOGRAPHY; KNEE ARTHRITIS; LABORATORY TEST; LARGE CELL LYMPHOMA; MALE; MELENA; MOUTH EXAMINATION; MOUTH ULCER; MULTIPLE CYCLE TREATMENT; NONHODGKIN LYMPHOMA; ODYNOPHAGIA; OPHTHALMOLOGY; POLYARTHRITIS; PROTEIN EXPRESSION; RASH; REMISSION; SCAR; SKIN DEFECT; TONSIL CANCER; TONSIL DISEASE; TONSIL HYPERTROPHY;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BEHCET SYNDROME; COMBINED MODALITY THERAPY; HUMANS; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; RADIOTHERAPY, ADJUVANT; REMISSION INDUCTION; TONSILLAR NEOPLASMS;

EID: 53149123983     PISSN: 1297319X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jbspin.2007.09.018     Document Type: Article

References (32)

1. Kinlen L.J. Malignancy in autoimmune diseases. J Autoimmun 5 Suppl. A (1992) 363-371
2. Cengiz M., Altundag M.K., Zorlu A.F., et al. Malignancy in Behçet's disease: a report of 13 cases and a review of the literature. Clin Rheumatol 20 (2001) 239-244
3. International Study Group for Behçet's Disease. Criteria for diagnosis of Behçet's disease. Lancet 335 (1990) 1078-1080
4. Celik I., Barista I., Tekuzman G., et al. Behçet disease: advantageous against development of neoplasia?. Ann Rheum Dis 55 (1996) 648
5. Bellier C., Khellaf M., Lambotte O., et al. Lymphome de Burkitt au cours d'un lupus systémique traité par immunosuppresseur. A propos d'un cas. La revue de médecine interne 27 (2006) 244-247
6. Sakane T., Takeno M., Suzuki N., et al. Behçet disease. N Engl J Med 341 (1999) 1248-1291
7. Harada K., Ohtsusru K., Nakayama K., et al. Intracranial primary malignant lymphoma following Behçet's disease - case report. No To Shinkei 44 (1992) 1029-1033
8. Abe T., Yachi A., Yabana T., et al. Gastric non-Hodgkin's lymphoma associated with Behçet's disease. Intern Med 32 (1993) 663-667
9. Yamamoto T., Tamura M., Hamauzu T., et al. Intestinal Behçet's disease associated with non-Hodgkin's lymphoma. J Gastroenterol 32 (1997) 241-245
10. Houman M.H., Ben Ghorbel I., B'chir S., et al. Intestinal lymphoma associated with Behçet's disease. Ann Intern Med 152 (2001) 415-418
11. Ono Y., Yamada M., Kawamura T., et al. Central nervous system malignant lymphoma associated with Behçet's disease. Neurol Med Chir (Tokyo) 45 (2005) 586-590
12. Moulonguet-Michau I., Blanc F., Cavelier-Balloy B., et al. Angiocentric lymphoma in Behçet's disease. Ann Dermatol Venereol 117 (1990) 885-887
13. Katsura Y., Suzukawa K., Kojima H., et al. Cytotoxic T-cell lymphoma arising in Behçet disease. Int J Hematol 77 (2003) 282-285
14. Kaneko H., Hojo Y., Nakajima H., et al. Behcet syndrome associated with nasal malignant lymphoma: a report of an autopsy case. Acta Pathol Jpn 24 (1974) 141-150
15. Houston K.A., O'Duffy J.D., and McDuffie F.C. Behçet's disease associated with a lymphoproliferative disorder, mixed cryoglobulinemia, and immune complex mediated vasculitis. J Rheumatol 5 (1978) 217-223
16. Ward H.A., Russo G.G., McBurney E., et al. Posttransplant primary cutaneous T-cell lymphoma. J Am Acad Dermatol 44 (2001) 675-680
17. King J.K., and Costenbader K.H. Characteristics of patients with systemic lupus erythematosus (SLE) and non-Hodgkin's lymphoma (NHL). Clin Rheumatol 26 (2007) 1491-1494
18. Ben Ghorbel I., Bellil K., Kchir M.N., et al. Systemic sclerosis and non Hodgkin lymphoma. Rev Med Intern 26 (2005) 993-996
19. Penn I. Malignant lymphomas in transplantation patients. Transplant Proc 1 (1969) 106-112
20. Vial T., and Descotes J. Immunosuppressive drugs and cancer. Toxicology 185 (2003) 229-240
21. Kassan S.S., Thomas T.L., Moutsopoulos H.M., et al. Increased risk of lymphoma in sicca syndrome. Ann Intern Med 89 (1978) 888-892
22. Zackheim H.S. Cyclosporine-associated lymphoma. J Am Acad Dermatol 40 (1999) 1015-1016
23. Cliff S., Pettengell R., Gharge S., et al. B-cell lymphoma developing in a patient on cyclosporin for recalcitrant psoriasis. Br J Dermatol 140 (1999) 763-765
24. Knight A., Askling J., and Ekbom A. Cancer incidence in a population-based cohort of patient with Wegener's granulomatosis. Int J Cancer 100 (2002) 82-85
25. Radis C.D., Kahl L.E., Baker G.L., et al. Effects of cyclophosphamide on the development of malignancy and on long-term survival of patients with rheumatoid arthritis. A 20-year follow-up study. Arthritis Rheum 38 (1995) 1120-1127
26. Wang Y.J., and Zhang L.S. Evaluation of the genotoxicity of vincristine and colchicine using mouse lymphoma tk mutation assay. Wej Sheng Yan Jiu 35 (2006) 179-181
27. Askling J., Klareskog L., Hjalgrim H., et al. Do steroids increase lymphoma risk? A case-control study of lymphoma risk in polymyalgia rheumatica/giant cell arteritis. Ann Rheum Dis 64 (2005) 1765-1768
28. Weshler Z., Leviatan A., Gordon R., et al. Development of Hodgkin's lymphoma in a patient with leprosy. Oncology 35 (1978) 281-284
29. Niaudet P. Post transplant lymphoproliferative disease following renal transplantation: a multicenter retrospective study of 41 cases observed between 1992 and 1996. Transplant Proc 30 (1998) 2816-2817
30. Timuragaoglu A. Posttransplant lymphoproliferative disorders in transplant recipients. Transplant Proc 38 (2006) 641-645
31. Thorley-Lawson D.A. Basic virological aspects of Epstein-Barr virus infection. Semin Hematol 25 (1988) 247-260
32. Wohrer S., Troch M., Zwerina J., et al. Influence of rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone on serologic parameters and clinical course in lymphoma patients with autoimmune diseases. Ann Oncol 18 (2007) 647-651